Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayers

Showing results (551-560 of 690) with videos related to

Pageof 69
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
Intact antigen receptor-mediated calcium signals in patients with early stage HIV-1 infectionT E Hickey, P J Blair, S Perfetto, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2023
Rubble pile asteroids are foreverFred Jourdan, Nicholas E Timms, Tomoki Nakamura, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2012
Short-term monotherapy with IDX184, a liver-targeted nucleotide polymerase inhibitor, in patients with chronic hepatitis C virus infectionJacob Lalezari, David Asmuth, Arnaldo Casiró, et al.
Vaccine|June 28, 2001
Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workersJ L Williams, C J Christensen, B J McMahon, et al.
AIDS Research and Human Retroviruses|February 1, 2007
Efficacy and safety of three doses of tipranavir boosted with ritonavir in treatment-experienced HIV type-1 infected patientsJoseph C Gathe, Gerald Pierone, Peter Piliero, et al.
Controlled Clinical Trials|April 18, 2001
The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trialR D MacArthur, L Chen, D L Mayers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2006
Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-week results of the RESIST-2 trialPedro Cahn, Jorge Villacian, Adriano Lazzarin, et al.
Molecular Genetics and Metabolism|May 26, 2023
Evaluating the strength of evidence for genes implicated in peroxisomal disorders using the ClinGen clinical validity framework and providing updates to the peroxisomal disease nomenclatureShruthi Mohan, Megan Mayers, Meredith Weaver, et al.
AIDS Research and Human Retroviruses|February 28, 2012
Recombination between variants from genital tract and plasma: evolution of multidrug-resistant HIV type 1Kimdar S Kemal, Christina M Ramirez, Harold Burger, et al.
Contemporary Clinical Trials|December 26, 2022
A community-informed recruitment plan template to increase recruitment of racial and ethnic groups historically excluded and underrepresented in clinical researchJennifer Cunningham-Erves, Yvonne Joosten, Sheila V Kusnoor, et al.
Pageof 69

Showing results (551-560 of 690) with videos related to

Sort By:
Pageof 69
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
Intact antigen receptor-mediated calcium signals in patients with early stage HIV-1 infectionT E Hickey, P J Blair, S Perfetto, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2023
Rubble pile asteroids are foreverFred Jourdan, Nicholas E Timms, Tomoki Nakamura, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2012
Short-term monotherapy with IDX184, a liver-targeted nucleotide polymerase inhibitor, in patients with chronic hepatitis C virus infectionJacob Lalezari, David Asmuth, Arnaldo Casiró, et al.
Vaccine|June 28, 2001
Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workersJ L Williams, C J Christensen, B J McMahon, et al.
AIDS Research and Human Retroviruses|February 1, 2007
Efficacy and safety of three doses of tipranavir boosted with ritonavir in treatment-experienced HIV type-1 infected patientsJoseph C Gathe, Gerald Pierone, Peter Piliero, et al.
Controlled Clinical Trials|April 18, 2001
The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trialR D MacArthur, L Chen, D L Mayers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2006
Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-week results of the RESIST-2 trialPedro Cahn, Jorge Villacian, Adriano Lazzarin, et al.
Molecular Genetics and Metabolism|May 26, 2023
Evaluating the strength of evidence for genes implicated in peroxisomal disorders using the ClinGen clinical validity framework and providing updates to the peroxisomal disease nomenclatureShruthi Mohan, Megan Mayers, Meredith Weaver, et al.
AIDS Research and Human Retroviruses|February 28, 2012
Recombination between variants from genital tract and plasma: evolution of multidrug-resistant HIV type 1Kimdar S Kemal, Christina M Ramirez, Harold Burger, et al.
Contemporary Clinical Trials|December 26, 2022
A community-informed recruitment plan template to increase recruitment of racial and ethnic groups historically excluded and underrepresented in clinical researchJennifer Cunningham-Erves, Yvonne Joosten, Sheila V Kusnoor, et al.
Pageof 69